https://scholars.lib.ntu.edu.tw/handle/123456789/627195
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Rimassa, Lorenza | en_US |
dc.contributor.author | Kelley, Robin Kate | en_US |
dc.contributor.author | Meyer, Tim | en_US |
dc.contributor.author | Ryoo, Baek-Yeol | en_US |
dc.contributor.author | Merle, Philippe | en_US |
dc.contributor.author | Park, Joong-Won | en_US |
dc.contributor.author | Blanc, Jean-Frederic | en_US |
dc.contributor.author | Lim, Ho Yeong | en_US |
dc.contributor.author | Tran, Albert | en_US |
dc.contributor.author | Chan, Yi-Wah | en_US |
dc.contributor.author | McAdam, Paul | en_US |
dc.contributor.author | Wang, Evelyn | en_US |
dc.contributor.author | ANN-LII CHENG | en_US |
dc.contributor.author | El-Khoueiry, Anthony B | en_US |
dc.contributor.author | Abou-Alfa, Ghassan K | en_US |
dc.date.accessioned | 2023-01-12T03:43:15Z | - |
dc.date.available | 2023-01-12T03:43:15Z | - |
dc.date.issued | 2022-01 | - |
dc.identifier.issn | 2235-1795 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/627195 | - |
dc.description.abstract | Cabozantinib, an inhibitor of MET, AXL, and VEGF receptors, significantly improved overall survival (OS) and progression-free survival (PFS) versus placebo in patients with previously treated advanced hepatocellular carcinoma (HCC). In this exploratory analysis, outcomes were evaluated according to plasma biomarker levels. | en_US |
dc.language.iso | en | en_US |
dc.publisher | KARGER | en_US |
dc.relation.ispartof | Liver cancer | en_US |
dc.subject | Cabozantinib; Hepatocellular carcinoma; Plasma biomarkers; Prognostic factors | en_US |
dc.title | Outcomes Based on Plasma Biomarkers for the Phase 3 CELESTIAL Trial of Cabozantinib versus Placebo in Advanced Hepatocellular Carcinoma | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1159/000519867 | - |
dc.identifier.pmid | 35222506 | - |
dc.identifier.scopus | 2-s2.0-85121125776 | - |
dc.identifier.isi | WOS:000729156900001 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85121125776 | - |
dc.relation.journalvolume | 11 | en_US |
dc.relation.journalissue | 1 | en_US |
dc.relation.pageend | 47 | en_US |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Oncology-NTUH | - |
crisitem.author.orcid | 0000-0002-9152-6512 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。